Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 16.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $659.191 million which beat the analyst consensus estimate of $619.033 million by 6.49 percent. This is a 18.23 percent increase over sales of $557.540 million the same period last year.
Amneal Pharmaceuticals Q1 2024 Adj EPS $0.14 Beats $0.09 Estimate, Sales $659.191M Beat $619.033M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.